Early clinical prediction of neurodevelopmental outcome in KCNQ2-related disorders

E. Van Boxstael C. Millevert M. Hairabedian C. Fons D. C. Alba Ting-Gee-An-Nie Chiu I. Scheffer L. Licchetta D. M. Cordelli E. Roza J. Lemke M. Krygier M. Pietruszka P. Gençpınar S. Dağdaş S. Syrbe T. B. Hammer I. V. Palafoll G. Lesca L. Chaton A. Schoonjans A. Jansen T. Niranjan C. Boßelmann L. Montanucci T. Brunger D. Lal M. Milh S. Weckhuysen Kcnq Study Group

Aug 2026 · medRxiv · 0 citations

Medicine

TL;DR

These prediction models demonstrate the feasibility of early prognostication in KCNQ2-RD and support future prospective external validation and enable more accurate individualised counselling by integrating clinical and genetic information readily available at time of genetic diagnosis.

DOI Semantic Scholar

View source

Similar papers

Open access Jul 2026

Clinical heterogeneity and diagnostic challenges in CASK-related neurodevelopmental disorders: a longitudinal observational study

CASK-related disorders may present with severe neurodevelopmental impairment and cerebral palsy–like phenotypes, even in the absence of characteristic neuroimaging findings, which should raise suspicion for CASK-related disorders.

I. Pacheva, Elena Timova, T. Todorov et al. · Frontiers in Psychiatry · 0 citations

Open access Aug 2026

Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders.

Earlier SCB initiation was associated with earlier seizure offset and more favourable developmental outcomes, underscoring the importance of early genetic diagnosis and timely SCB therapy, and the use of SCBs, particularly CBZ and OXC, as first-line therapy in (LOF) KCNQ2-DEE and SeL(F)NE is supported.

C. Millevert, M. Hairabedian, Samuel Dahan et al. · Brain : a journal of neurolo... · 1 citation

Open access Jul 2026

The KCNT1-Related Epilepsy Study

The first-ever prospective natural history study to comprehensively clinically phenotype individuals affected by KCNT1-related epilepsy is initiated, presenting the study design and methods and several challenges that arose in its implementation and discusses various solutions implemented in this medically complex popu...

Heather R. Adams, Viet Nguyen, L. Seltzer et al. · Neurology: Genetics · 0 citations

Review Open access Aug 2026

Clinical phenotype spectrum and prognostic analysis of DNM1L-related disorders: a single-center cohort study of 18 patients

“hemiconvulsion-hemiplegia-epilepsy syndrome” is identified as a distinct feature and potential prognostic indicator for middle domain variants in DNM1L variants, which are predominantly missense, with the middle domain as a hotspot.

Han Xu, Chao-Long Xu, Ying Zou et al. · Frontiers in Neurology · 0 citations

Review Open access Aug 2026

PPP1R21-Related neurodevelopmental disorder: Phenotypic delineation, variant spectrum, and pathophysiological mechanisms

PPP1R21-related neurodevelopmental disorder (PPP1R21-NDD) is an ultra-rare autosomal-recessive encephalopathy caused by dysfunction of the Five-subunit Endosomal Rab5 and RNA/ribosome intermediarY (FERRY) complex. To delineate the clinical, neuroimaging, and molecular spectrum of PPP1R21-NDD and outline diagnostic and...

F. Comisi, G. Di Pasquale, A. Comisi et al. · Neurogenetics · 0 citations

Jul 2026

Environmental and treatment-related factors associated with developmental outcomes in genetic epilepsies.

The findings highlight genetic NDDs as genome-informed yet exposure-sensitive disorders and several external factors that both represent markers of epilepsy severity and may support early, genetically informed seizure management and careful stewardship of treatment exposures.

C. Boßelmann, Natasha N. Ludwig, C. Holingue et al. · Epilepsia · 0 citations